Chemical Tools for Probing Histone Deacetylase (HDAC) Activity

被引:0
|
作者
Masafumi Minoshima
Kazuya Kikuchi
机构
[1] Osaka University,Graduate School of Engineering
[2] Osaka University,Institute of Academic Initiatives
[3] Osaka University,Immunology Frontier Research Center (IFReC)
来源
Analytical Sciences | 2015年 / 31卷
关键词
Histone deacetylase; fluorogenic probes; activity-based probes; positron emission tomography;
D O I
暂无
中图分类号
学科分类号
摘要
Histone deacetylases (HDACs) enzymes are responsible for removing epigenetic markers on histone proteins, which results in chromatin inactivation and gene repression. An evaluation of HDAC activity is essential for not only determining the physiological function of HDACs, but also for developing HDAC-targeting drugs. This review focuses on the chemical tools used to detect HDAC activity. We highlight activity-based probes and positron emission tomography probes based on the chemical structure of the inhibitors. We also summarize fluorogenic probes used in single-step methods for HDAC detection. These fluorogenic probes are designed based on the nucleophilicity of the amino group, aggregation via electrostatic interactions, and changes in the DNA binding properties. These fluorogenic systems may enable facile and rapid screening to evaluate HDAC inhibitors, which will contribute to the development of epigenetic drugs.
引用
收藏
页码:287 / 292
页数:5
相关论文
共 50 条
  • [41] Synthesis of Sulfonamides and Evaluation of Their Histone Deacetylase (HDAC) Activity (vol 12, pg 1125, 2007)
    Oh, Seikwan
    Moon, Hyung-In
    Son, Il-Hong
    Jung, Jae-Chul
    Avery, Mitchell A.
    MOLECULES, 2009, 14 (05) : 1950 - 1951
  • [42] Structure-activity relationship study on histone deacetylase (HDAC) inhibitors derived from Santacruzamate
    Hogle, Emily
    Onate, Alma
    Tucker, Janelle
    Leduc, Rachel
    Thuy Do
    Klein, Reid
    Thowfeik, Fathima
    Merino, Edward
    Ma, Lili
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
  • [43] Regulation of Histone Deacetylase 6 (HDAC6) Activity via S-Nitrosylation
    Okuda, Kosaku
    Ito, Akihiro
    Uehara, Takashi
    FREE RADICAL BIOLOGY AND MEDICINE, 2016, 100 : S43 - S43
  • [44] Activity of the histone deacetylase (HDAC) inhibitor PXD101 in preclinical prostate cancer studies
    Jeffers, M.
    Qian, X.
    Mills, E.
    LaRochelle, W.
    Lichenstein, H.
    Ara, G.
    EJC SUPPLEMENTS, 2006, 4 (12): : 109 - 109
  • [45] Histone deacetylase (HDAC) inhibitor trichostatin A enhances the activity of oncolytic adenoviruses in ovarian cancer virotherapy
    Hulin-Curtis, Sarah
    Davies, James
    Chester, John
    Parker, Alan
    HUMAN GENE THERAPY, 2017, 28 (08) : A22 - A22
  • [46] HDAC (HISTONE DEACETYLASE) EXPRESSION PATTERNS IN UROTHELIAL CANCER AND THEIR IMPACT ON THE ACTION OF HDAC INHIBITORS
    Niegisch, G.
    Knievel, J.
    Koch, A.
    Albers, P.
    Schulz, W. A.
    EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (02) : 165 - 166
  • [47] Design, synthesis and anticancer activity of novel valproic acid conjugates with improved histone deacetylase (HDAC) inhibitory activity
    Ibrahim, Tarek S.
    Sheha, Taghreed A.
    Abo-Dya, Nader E.
    AlAwadh, Mohammed A.
    Alhakamy, Nabil A.
    Abdel-Samii, Zakaria K.
    Panda, Siva S.
    Abuo-Rahma, Gamal El-Din A.
    Mohamed, Mamdouh F. A.
    BIOORGANIC CHEMISTRY, 2020, 99
  • [48] Different histone deacetylase (HDAC) expression in leukemic cell with or without resistance to HDAC inhibitors
    Liu, Ren-Shyan
    Kao, Chieh-Ling
    Hsiao, Liang-Tsai
    Yen, Chueh-Chuan
    Wu, Chun-Yi
    Wang, Hsin-Ell
    Chen, Po-Min
    JOURNAL OF NUCLEAR MEDICINE, 2010, 51
  • [49] Probing phosphorylation-dependent protein interactions within functional domains of histone deacetylase 5 (HDAC5)
    Guise, Amanda J.
    Mathias, Rommel A.
    Rowland, Elizabeth A.
    Yu, Fang
    Cristea, Ileana M.
    PROTEOMICS, 2014, 14 (19) : 2156 - 2166
  • [50] Histone Deacetylase Cytoplasmic Trapping by a Novel Fluorescent HDAC Inhibitor
    Kong, Yali
    Jung, Mira
    Wang, Kan
    Grindrod, Scott
    Velena, Alfredo
    Lee, Sung A.
    Dakshanamurthy, Sivanesan
    Yang, Yonghong
    Miessau, Matthew
    Zheng, Chaoyi
    Dritschilo, Anatoly
    Brown, Milton L.
    MOLECULAR CANCER THERAPEUTICS, 2011, 10 (09) : 1591 - 1599